India Strengthens Bulk Drug Manufacturing as PLI Investments Cross ₹5,210 Crore
India is one of the world’s major producers and exporters of pharmaceutical formulations. However, domestic manufacturers have historically depended on imports for several critical Active Pharmaceutical Ingredients (APIs), Drug Intermediates (DIs) and Key Starting Materials (KSMs) required for medicine production.